Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI) Income Statement


Puma Biotechnology Income Statement

Last quarter (Q4 2023), Puma Biotechnology's total revenue was $72.18M, an increase of 9.90% from the same quarter last year. In Q4, Puma Biotechnology's net income was $12.27M. See Puma Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 229.66M$ 235.64M$ 228.03M$ 253.16M$ 225.11M$ 272.26M
Cost of Revenue
$ 36.25M$ 62.68M$ 55.09M$ 63.70M$ 39.37M$ 36.81M
Gross Profit
$ 199.39M$ 172.96M$ 172.94M$ 189.45M$ 185.74M$ 235.44M
Operating Expense
$ 69.93M$ 140.31M$ 149.22M$ 188.16M$ 216.14M$ 273.31M
Operating Income
$ 129.46M$ 32.64M$ 23.72M$ 1.29M$ -30.40M$ -37.86M
Net Non Operating Interest Income Expense
$ -10.72M$ -10.72M$ -10.78M$ -12.65M$ -13.56M$ -12.17M
Other Income Expense
$ -759.00K$ -759.00K$ 12.48M$ 9.30M$ -15.83M$ -25.51M
Pretax Income
$ 22.67M$ 22.67M$ 457.00K$ -20.66M$ -59.79M$ -75.54M
Tax Provision
$ 1.08M$ 1.08M$ 455.00K$ 8.47M$ 207.00K$ 53.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 118.41M$ 21.59M$ 2.00K$ -29.13M$ -59.99M$ -75.59M
Basic EPS
$ 0.46$ 0.46-$ -0.72$ -1.52$ -1.95
Diluted EPS
$ 0.46$ 0.45-$ -0.72$ -1.52$ -1.95
Basic Average Shares
$ 188.54M$ 47.13M$ 44.67M$ 40.64M$ 39.58M$ 38.77M
Diluted Average Shares
$ 190.20M$ 47.55M$ 44.93M$ 40.64M$ 39.58M$ 38.77M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
----$ -0.59$ -0.47
Reported Normalized Diluted E P S
----$ -0.59$ -0.47
Rent Expense Supplemental
Total Expenses
$ 106.18M$ 203.00M$ 204.31M$ 251.87M$ 255.51M$ 310.12M
Net Income From Continuing And Discontinued Operation
$ 21.59M$ 21.59M$ 2.00K$ -29.13M$ -59.99M$ -75.59M
Normalized Income
$ 14.86M$ 17.91M$ 361.03K-$ -48.17M$ -56.88M
Interest Expense
----$ 14.05M$ 15.02M
$ 36.00M$ 36.00M$ 12.05M$ -7.85M$ -45.74M$ -60.52M
$ 26.79M$ 47.52M$ 20.97M$ 2.75M$ -35.71M$ -52.45M
Currency in USD

Puma Biotechnology Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis